Blog

Regen BioPharma Press Release Feb 24, 2016: Regen BioPharma, Inc., announced today the completion of experiments, in collaboration with ‪PNI‬ Neuro-oncologist and ‪JWCI‬ researcher, Dr. Santosh Kesari, demonstrating immunological mechanisms of its novel NR2F6 gene silencing approach. The Company has begun the process of compiling an...

by Guest Writer Dr. Patti Johnson It takes Two – You and Your Support Team A chronic condition is one that persists over time without an easily definable beginning, middle and end. After being diagnosed with a chronic condition, such as some types of brain...

Unfortunately there is no clear answer to this question. At this time, seeking out top neurosurgeons and high quality neuro-oncological care is the only way we have of dealing of brain, pituitary and skull base tumors. Looking at risk factors can give us some insight but nothing...